Cumberland Pharmaceuticals (CPIX) Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Operating Expenses data on file, last reported at $12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 17.65% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $49.2 million (up 10.82% YoY), and the FY2025 full-year result was $47.3 million, up 6.8% from the prior year.
• Operating Expenses declined to $12.3 million in Q1 2026, from $15.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $15.5 million in Q4 2023 to a low of $10.3 million in Q3 2025.
• A 5-year average of $11.8 million and a median of $11.6 million in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 36.23% in 2023 and declined 20.95% in 2024, its largest moves.
• Tracing CPIX's Operating Expenses over 5 years: stood at $11.4 million in 2022, then surged by 36.23% to $15.5 million in 2023, then declined by 20.95% to $12.3 million in 2024, then rose by 22.58% to $15.0 million in 2025, then fell by 18.53% to $12.3 million in 2026.
• Business Quant data shows CPIX's Operating Expenses at $12.3 million in Q1 2026, $15.0 million in Q4 2025, and $10.3 million in Q3 2025.